Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase...

Details Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase... Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase...

2006-08-23

2009-10-27

Coleman, Brenda L (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C514S262100, C544S244000, C544S262000

Reexamination Certificate

active

07608603

ABSTRACT:
Compounds of formula Ia, Ib, Ic, Id, Ie, If, Ig or Ih:wherein X and Y are nitrogen or one of X and Y is nitrogen and the other is CRg, and W, D, E, R4, R5, R6and Rgare as defined herein. Also disclosed are methods of making the subject compounds and methods of using the compounds in the treatment of p38 MAP kinase-mediated diseases.

REFERENCES:
patent: 6383790 (2002-05-01), Shokat
patent: 2004/0180896 (2004-09-01), Munson et al.
patent: 2005/0197340 (2005-09-01), Arora et al.
patent: WO 2004/11303 (2005-09-01), None

Affiliated with

Also associated with

Rating

Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4077198